Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018

NEXT STORY
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
PREV STORY
Merit Medical Reports Record Revenues for First Quarter of 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2017

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2017 Amsterdam, ...

author_avatar
NASDAQ Market News

Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction

author_avatar
NASDAQ Market News

Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021

author_avatar
NASDAQ Market News